# Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer

> **NCT05488626** · NA · WITHDRAWN · sponsor: **Varian, a Siemens Healthineers Company**

## Conditions studied

- Stage III Non-small Cell Lung Cancer

## Interventions

- **DEVICE:** Adaptive Radiotherapy
- **DEVICE:** Non-Adaptive Radiotherapy
- **DRUG:** Chemotherapy
- **DRUG:** Immunotherapy

## Key facts

- **NCT ID:** NCT05488626
- **Lead sponsor:** Varian, a Siemens Healthineers Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-10-20
- **Primary completion:** 2027-12
- **Final completion:** 2028-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Shifting patterns of care for the target population.
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05488626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05488626, "Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05488626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*